To our knowledge, this is the first study to investigate the SUVmax value in Ga-68 PSMA PET/CT in staging and determining the disease burden (oligometastatic or multimetastatic) for PCa patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.